You have 9 free searches left this month | to do more

ipilimumab

Ipilimumab is a drug used to treat Melanoma, Metastatic Melanoma, Prostate Cancer, and other conditions. Ipilimumab is being actively studied in 263 studies and prior, has been studied in 90.

Top SponsorsTop SitesTop Investigators
Bristol-Myers SquibbLocal InstitutionInna Chen, MD
M.D. Anderson Cancer CenterDana Farber Cancer InstituteTheodore Sunki Hong
National Cancer Institute (NCI)Memorial Sloan Kettering Cancer CenterBradley A. McGregor
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Recruiting
  • Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
2021-08-06
Aug 6, 2021
U
Active, not recruiting
  • Melanoma
  • Aurora, Colorado
    University of Colorado Hospital
2021-09-27
Sep 27, 2021
L
Terminated
  • Prostatic Neoplasms
  • PROSTVAC V/F
  • Ipilimumab
  • San Francisco, California
    University of California, San Francisco
2021-10-25
Oct 25, 2021
D
Active, not recruiting
  • Thyroid Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-07-15
Jul 15, 2021
R
Active, not recruiting
  • Renal Cell Carcinoma
  • Washington, District of Columbia
  • +1 more
2021-07-26
Jul 26, 2021
U
Terminated
  • Metastatic Melanoma
  • Brain Metastases
  • Ipilimumab
  • Stereotactic Radiosurgery
  • Ann Arbor, Michigan
    University of Michigan Hospital
2021-04-20
Apr 20, 2021
A
Completed
  • Metastatic Melanoma
  • Ipilimumab
  • Stereotactic Body Radiation Therapy
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the Universirty of Pennsylvania
2021-07-19
Jul 19, 2021
G
Recruiting
  • Hepatocellular Carcinoma
  • Villejuif, France
    Gustave Roussy
2021-03-29
Mar 29, 2021
D
Recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-11-10
Nov 10, 2021
D
Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
2021-07-13
Jul 13, 2021
S
Recruiting
  • Nerve Sheath Tumors
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
2021-06-09
Jun 9, 2021
N
Recruiting
  • Metastatic Solid Tumors
  • Treatment-Refractory Cancers
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-27
Oct 27, 2021
H
Active, not recruiting
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
U
Completed
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
2021-10-22
Oct 22, 2021
N
Recruiting
  • Nasopharyngeal Carcinoma
  • Singapore, Singapore
    National Cancer Center Singapore
2021-05-24
May 24, 2021
M
Active, not recruiting
  • Advanced Cancers
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-10-31
Oct 31, 2021
U
Active, not recruiting
  • Malignant Melanoma
  • Ipilimumab
  • +2 more
  • Oslo, Norway
    Oslo University Hospital, Radiumhospitalet
2021-05-14
May 14, 2021
A
Completed
  • Mucinous Neoplasm
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-12-02
Dec 2, 2021
N
Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute LAO
2021-10-21
Oct 21, 2021
H
Active, not recruiting
  • Small Cell Lung Cancer
  • Extensive-stage Small Cell Lung Cancer
  • Thoracic Radiation Therapy
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-09-13
Sep 13, 2021
U
Not yet recruiting
  • Mesothelioma
  • Peritoneal Mesothelioma
  • (no location specified)
2021-11-02
Nov 2, 2021
N
Recruiting
  • Mesothelioma
  • LMB-100
  • ipilimumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-11-06
Nov 6, 2021
D
Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +2 more
2021-09-27
Sep 27, 2021
E
Terminated
  • Metastatic Melanoma
  • +2 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
2021-03-26
Mar 26, 2021
M
Not yet recruiting
  • Brain Metastases
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-11
Oct 11, 2021